AMGN Stock — Price, Charts & Analysis

Amgen Inc. (AMGN) has a trailing P/E of 26.94x and a forward P/E of 17.78x. This places AMGN in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

AMGN trades with 26.94x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether AMGN looks overvalued or undervalued.

AMGN's P/E of 26.94x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

AMGN's trailing EPS is $16.10 and forward EPS is $24.40. Reported earnings growth is 64.90%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Amgen Inc. generated for each share. AMGN's trailing EPS is $16.10, and investors usually prefer EPS that is positive and growing over time.

Amgen Inc. has a market cap of $234.09B, making AMGN a large-cap stock based on the current market value shown on Worldtickers.

AMGN's latest stock price on Worldtickers is $433.73. The latest move is -$8.63 or -1.95%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

AMGN's quote includes a latest price of $433.73. The market open is $435.78. Previous close is $442.36. The intraday range is $431.07 to $441.02.

AMGN is down in the latest quote, with a move of -$8.63 or -1.95%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

AMGN generated $38.09B in trailing revenue. Revenue growth is 9.50%, which helps show whether demand is expanding or slowing.

AMGN's revenue growth is 9.50%, which is a positive demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, AMGN shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is $8.74B.

Gross margin is 71.89%. Margins show how efficiently Amgen Inc. turns revenue into profit.

Amgen Inc. carries $57.30B and holds $13.99B in cash.

AMGN holds $13.99B on its balance sheet.

AMGN's book value per share is $21.62.

Yes, Amgen Inc. pays a dividend of $10.08 per share annually. The dividend yield is 228.00%. The payout ratio is 60.87%.

AMGN's dividend yield is 228.00%. Its payout ratio is 60.87%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for AMGN. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Amgen Inc.'s investor relations materials.

AMGN's five-year average dividend yield is 307.00%. Use this alongside current yield, payout ratio, and cash flow to understand whether today's dividend looks high or low versus recent history.

Institutions hold 85.12% of AMGN shares. Insiders hold 0.22% of shares. Ownership mix helps investors understand how much of Amgen Inc. is held by professional investors and company insiders.

AMGN has 539.71M shares outstanding. Float shares are 539.16M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for AMGN, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for AMGN is $24.40. Earnings growth is 64.90%. Revenue growth is 9.50%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

AMGN's trailing EPS is $16.10. Forward EPS is $24.40. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

AMGN is in the Healthcare sector. Its earnings multiple is 26.94x. Its latest displayed growth metric is 9.50%. Compare these figures with sector peers before deciding whether Amgen Inc. is stronger or weaker than average.

AMGN trades at $433.73. The stock trades at 26.94x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Amgen Inc.'s fundamentals.

AMGN risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.41, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

AMGN should be compared with companies in Drug Manufacturers - General. Its earnings multiple is 26.94x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Amgen Inc. (AMGN) operates in Healthcare, specifically Drug Manufacturers - General. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction,

AMGN trades on NasdaqGS. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

AMGN stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Amgen Inc.'s official website listed on Worldtickers is investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Amgen Inc. employs about 31.5K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Amgen Inc. is headquartered in Thousand Oaks, CA, United States. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

AMGN is in the Healthcare sector and the Drug Manufacturers - General industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

AMGN has traded between $269.77 and $443.20 over the past 52 weeks. At $433.73, it is 2.14% below the high and 60.78% above the low. The 52-week range helps gauge long-term price momentum.

AMGN is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is $376.93 and its 200-day moving average is $349.44.

AMGN's RSI is 71.53. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a overbought momentum setup.

AMGN's latest RSI reading is 71.53, which points to overbought momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for AMGN is near $359.21. Key resistance is near $443.20. Breaks above resistance or below support can change the short-term technical setup.

AMGN's nearest reported support level is $359.21. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

AMGN's nearest reported resistance level is $443.20. A breakout above resistance can improve momentum, especially when volume confirms the move.

AMGN trades about 2.68M shares daily on average. The latest displayed volume is 2.72M shares. Volume helps show liquidity and whether trading interest is unusually high or low.

AMGN's MACD is 2.13, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

AMGN is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 71.53 (overbought). MACD is bullish. Nearest support is around $359.21. Resistance is around $443.20. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $404.99 (7.10% from price). MA50 is $376.93 (15.07% from price). MA200 is $349.44 (24.12% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. AMGN's MA20 is $404.99. MA50 is $376.93. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

AMGN's pivot is near $438.31. Support is near $359.21. Resistance is near $443.20. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for AMGN is near $410.40. These levels help define risk and possible follow-through zones after a breakout or breakdown.

AMGN's Bollinger range is roughly $366.99 to $443.00. Band width is near 18.77%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

AMGN's ATR-based typical daily range is about 2.53%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 2.72M shares. Average volume is about 2.68M shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

AMGN's all-time high shown on Worldtickers is $443.20. Its all-time low is $0.08. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

AMGN has a beta of 0.41, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.